Pattern-reversal visual-evoked potential in patients with occult macular dystrophy
Gen Hanazono1,2, Hisao Ohde2,3, Kei Shinoda1,4, Kazushige Tsunoda1,2, Kazuo Tsubota2, Yozo Miyake1,5
1Department of Ophthalmology, National Institute of Sensory Organs, Tokyo, Japan; 2Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan; 3Kamoshita Eye Clinic, Tokyo, Japan; 4Department of Ophthalmology, Teikyo University School of Medicine, Tokyo, Japan; 5Aichi Medical School, Aichi, Japan
Purpose: Occult macular dystrophy (OMD) is a hereditary retinal disease characterized by a normal fundus, normal full-field electroretinograms (ERGs), progressive decrease of visual acuity, and abnormal focal macular ERGs. The purpose of this study was to report pattern-reversal visual-evoked potential (pVEPs) findings in OMD patients.
Patients and method: The pVEPs recorded from four patients with OMD (aged 42–61 years; 2 men and 2 women) were reviewed. The visual acuities ranged from 20/200 to 20/30. The amplitudes of the N-75 and P-100 (P2 amplitude) and the latency of the N-75 components (N1 latency) were analyzed.
Results: The mean (±SD) P2 amplitude was 2.7 ± 1.9 µV for the 5´, 4.8 ± 2.9 µV for the 10´, 3.2 ± 2.1 µV for the 20´, and 4.4 ± 3.5 µV for the 40´ checkerboard stimuli. The N1 latency was 122.2 ± 6.4 ms for the 5´, 105.0 ± 11.5 ms for the 10´, 97.7 ± 10.0 ms for the 20´, and 91.0 ± 13.7 ms for the 40´ checkerboard stimuli. The mean P2 amplitude was reduced and the N1 latency was delayed in comparison with the laboratory standard for the Keio University Hospital.
Conclusions: The delayed latency and reduced amplitude suggest a major contribution of the central cone pathway to the pVEPs.
Keywords: occult macular dystrophy, visual-evoked potential, electroretinogram
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]